| Literature DB >> 23725882 |
Jennifer M Spaethling1, James H Eberwine.
Abstract
Single cell sequencing is currently in its relative infancy although an unprecedented amount of information is already being generated. These techniques are providing new insight into intercellular variability as well as identification of previously unrecognized drug targets. As more groups are gaining an interest in this fruitful technique, new sample preparation techniques, sequencing platforms, and bioinformatics tools are being developed which only improve the quantity and quality of data generated in these studies. Great advancements in harvest (in vivo pipette), sample preparation, and sequencing (Illumina HiSeq 2500/MiSeq, Ion Torrent PGM, Pacific Biosciences RS) are allowing for previously untestable questions to be answered and for expanded accessibility of these technologies.Entities:
Mesh:
Year: 2013 PMID: 23725882 DOI: 10.1016/j.coph.2013.04.011
Source DB: PubMed Journal: Curr Opin Pharmacol ISSN: 1471-4892 Impact factor: 5.547